MedPath

Study held to see the effect of yapan basti on post covid 19 symptoms

Phase 2
Conditions
Health Condition 1: J989- Respiratory disorder, unspecifiedHealth Condition 2: J989- Respiratory disorder, unspecified
Registration Number
CTRI/2021/11/038239
Lead Sponsor
Dr Pratima Naresh Gawand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients suffering from post covid 19 symptoms will be taken as a subject to study

age above 20 yrs and not less than 60

Exclusion Criteria

patients with mucormycosis

patients with bronchioalveolar carcinoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sahacharadi yapan basti is effective in post covid 19 symptoms subjective criteria will be 1)fatique 2)dysapnea 3)cough 4)myalgia <br/ ><br>objective crieteria 1)cbc 2)c reative protein 3)esr 4)6 min walking test 5)lung function testTimepoint: 16 days with follow 3 follow up (8,17,32 days)
Secondary Outcome Measures
NameTimeMethod
reduction in grades of post covid 19 symptoms like lung capacity improvement will be studiedTimepoint: 16 days with follow 3 follow up (8,17,32 days)
© Copyright 2025. All Rights Reserved by MedPath